Day: November 17, 2021

Todos Medical Announces Addition of Semi-Quantitative Titer Claims to the Emergency Use Authorization for the cPass Neutralizing Antibody Test

Todos Medical Announces Addition of Semi-Quantitative Titer Claims to the Emergency Use Authorization for the cPass Neutralizing Antibody Test

·       Reauthorization of EUA expands beyond initial qualitative detection claim ·       CEO to appear on Cheddar News at 6:10pm tonight, November 17th, 2021 New York, NY, and Tel Aviv, ISRAEL, Nov. 17, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that the United States Food & Drug Administration has reauthorized the Emergency Use Authorization (EUA) for the cPass neutralizing antibody test (“cPass”)*. The new indication for cPass now reads: Qualitative and semi-quantitative direct detection of total neutralizing antibodies to SARS-CoV-2 in human serum and dipotassium EDTA plasma. Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or...

Continue reading

Eneti Inc. Announces Purchase of Common Shares by the President of the Company

Eneti Inc. Announces Purchase of Common Shares by the President of the Company

MONACO, Nov. 17, 2021 (GLOBE NEWSWIRE) — Eneti Inc. (NYSE:NETI) (the “Company”) announced today that the President of the Company, Robert Bugbee, has recently purchased 25,000 common shares of the Company at an average price of $8.64 per share in the open market. About Eneti Inc. Eneti Inc. is focused on the offshore wind and marine-based renewable energy industry and has invested in the next generation of wind turbine installation vessels. Additional information about the Company is available on the Company’s website www.eneti-inc.com, which is not a part of this press release. Forward-Looking Statements Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies...

Continue reading

JOYY Reports Third Quarter 2021 Unaudited Financial Results

JOYY Reports Third Quarter 2021 Unaudited Financial Results

SINGAPORE, Nov. 18, 2021 (GLOBE NEWSWIRE) — JOYY Inc. (NASDAQ: YY) (“JOYY” or the “Company”, formerly known as YY Inc.), a global video-based social media company, today announced its unaudited financial results for the third quarter of 2021. Third quarter 2021 Financial Highlights1 Net revenues increased by 21.7% to US$650.5 million from US$534.4 million in the corresponding period of 2020. Net Income from continuing operations attributable to controlling interest of JOYY2 was US$7.5 million, compared to US$191.0 million in the corresponding period of 2020. Net income from continuing operations attributable to controlling interest of JOYY was higher in the third quarter of 2020 primarily due to the gain from partial disposal of investments in Huya in the third quarter of 2020. Non-GAAP net income from continuing operations attributable...

Continue reading

MANUFACTURED HOUSING PROPERTIES INC. ANNOUNCES RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021

MANUFACTURED HOUSING PROPERTIES INC. ANNOUNCES RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021

– Revenues and EBITDA Increased 33% and 10%, respectively, Over Prior Period for the Quarter Ended September 30, 2021, And Revenues and EBITDA Increased 24% and 11%, respectively, Over Prior Period for the Nine Months Ended September 30, 2021 Charlotte, North Carolina, Nov. 17, 2021 (GLOBE NEWSWIRE) — Manufactured Housing Properties Inc. (OTC: MHPC), which acquires, owns, and operates 37 manufactured housing communities containing approximately 1,743 developed sites, today announced operating results for the quarter ended September 30, 2021. Total revenues and EBITDA for the quarter ended September 30, 2021 were $2,259,169 and $960,687, respectively, compared to $1,700,963 and $873,088, respectively, for the quarter ended September 30, 2020. Total revenues and EBITDA for the nine months ended September 30, 2021 were $5,764,471...

Continue reading

Atlanticus Prices $135 Million Offering of Senior Notes

Atlanticus Prices $135 Million Offering of Senior Notes

ATLANTA, Nov. 17, 2021 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” “the Company”, “we,” “our” or “us”), a financial technology company which enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced the pricing of its underwritten registered public offering (the “Offering”) of $135 million aggregate principal amount of 6.125% Senior Notes due 2026 (the “Notes”). The Company has granted the underwriters a 30-day option to purchase up to an additional $15 million aggregate principal amount of the Notes in connection with the Offering. The Offering is expected to close on or about November 22, 2021, subject to customary closing conditions. The Company expects to use the net proceeds of this Offering for general...

Continue reading

Flex LNG - Mandatory notification of trade by primary insiders

Flex LNG – Mandatory notification of trade by primary insiders

Øystein M Kalleklev, CEO of Flex LNG Management AS, has today exercised 60,000 stock options vested in the period September 7, 2018 to September 7, 2021. The original strike price was $14.3 per share, but have been adjusted to $12.9 (the “Adjusted Strike Price”) due to $1.4 dividend paid per share since the options were granted. The stock options have been cash settled with the difference of the Adjusted Strike Price and the closing price at NYSE on November 17, 2021 of $22.78. Following the exercising of these stock options, Mr. Kalleklev holds 50,000 shares in Flex LNG Ltd. as well as 250,000 stock options vesting over the period August 16, 2021 to September 7, 2024 with an average original strike price of $15.84. The strike price under these stock options is also adjusted for dividend payments. Please see the attached form for notification...

Continue reading

Biofrontera reports financial results for the third quarter and nine months ended September 30, 2021

Biofrontera reports financial results for the third quarter and nine months ended September 30, 2021

Leverkusen, Germany, Nov. 17, 2021 (GLOBE NEWSWIRE) — Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the nine months ended September 30, 2021. Key financial figures and business performance for the nine months ended September 30, 2021 In EUR thousands 9M 2021 9M 2020 Change Q3 2021 Q3 2020 Change Revenue 18,473   20,829   (11 )% 5,379   4,713   14 % thereof from product sales 18,473   14,337   29 % 5,379   4,661   15 % Gross profit on sales 15,761   18,262   (14 )% 4,680   3,637   29 % Research and development costs (4,516 ) (3,403 ) 33 % (1,595 ) (1,014 ) 57 % General and administrative costs (7,557 ) (6,882 ) 10 % (2,004 ) (2,410 ) 19 % Sales and marketing costs (16,263 ) (16,340 ) 0 % (6,072 ) (4,189 ) 45 % Profit...

Continue reading

VPG Appoints Sejal Shah Gulati as New Independent Director

VPG Appoints Sejal Shah Gulati as New Independent Director

Sejal Shah Gulati Sejal Shah Gulati is VPG’s newest addition to its Board of Directors. MALVERN, Pa., Nov. 17, 2021 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leading producer of precision sensors and sensor-based systems, today announced the appointment of Sejal Shah Gulati as an independent member to its Board of Directors, effective January 1, 2022. Marc Zandman, Chairman of the Board of Vishay Precision Group, said, “We are pleased to have Sejal join our board. She brings considerable expertise and demonstrated success in digital marketing and business management at both large companies and start-ups. We look forward to benefiting from her strategic counsel as we continue to work to build additional value for our stockholders.” Ms. Gulati currently serves as the Chief Growth Officer...

Continue reading

Marrone Bio Achieves Excellent Climate Impact Score for Venerate® XC Bioinsecticide

Marrone Bio Achieves Excellent Climate Impact Score for Venerate® XC Bioinsecticide

DAVIS, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions published today their independent climate impact product assessment on Venerate® XC Bioinsecticide, scoring a 8.6 out of 10. The analysis evaluated the life-cycle inputs and impacts of Venerate XC per acre on the following: soil, aquatic and human toxicity, ecosystem impact, harmful materials, greenhouse gas (GHG) emissions and carbon return on investment (CROI). “MBI is committed to providing farmers with the most effective products that not only produce healthier, more robust crops, but also meet the increasing demand for more sustainably grown goods,” stated Kevin Helash, chief executive officer for Marrone Bio Innovations. “This third party analysis...

Continue reading

Duck Creek Technologies Continues Investment in the Australian Market

Duck Creek Technologies Continues Investment in the Australian Market

Leading insurance SaaS firm expands its local product templates to include workers’ compensation functionality out of the box Sydney, Nov. 17, 2021 (GLOBE NEWSWIRE) — Duck Creek Technologies (Nasdaq: DCT) announced today that it has further continued its investment in the Australian market, releasing several key software packages and setting up a regional product development team to cater to the needs of its current and future customers in the region. “Our sincere belief is that localization of our product and its ongoing support should be our responsibility, not something our systems integrator partners or customers should have to worry about,” said Shaji Sethu, Managing Director for Asia Pacific at Duck Creek Technologies. Duck Creek will now be the first significant platform provider to the Australian workers’ compensation market...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.